SNRPN | Small nuclear ribonucleoprotein polypeptide N | Plasma proteins
| | | | | Expressed in all |
TJP1 | Tight junction protein 1 | | | | | | Mixed |
CHRNA7 | Cholinergic receptor, nicotinic, alpha 7 (neuronal) | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
SCG5 | Secretogranin V (7B2 protein) | Predicted secreted proteins
| | | | | Tissue enhanced |
AVEN | Apoptosis, caspase activation inhibitor | | | | | | Expressed in all |
NOP10 | NOP10 ribonucleoprotein | Disease related genes
| | | | | Expressed in all |
NUTM1 | NUT midline carcinoma, family member 1 | Cancer-related genes Disease related genes
| | | | | Tissue enriched |
ACTC1 | Actin, alpha, cardiac muscle 1 | Disease related genes Plasma proteins
| | | | | Tissue enriched |
ZNF770 | Zinc finger protein 770 | Transcription factors
| | | | | Expressed in all |
MEIS2 | Meis homeobox 2 | Transcription factors
| | | | | Mixed |
TMCO5A | Transmembrane and coiled-coil domains 5A | Predicted membrane proteins
| | | | | Tissue enriched |
FAM98B | Family with sequence similarity 98, member B | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
THBS1 | Thrombospondin 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
C15orf52 | Chromosome 15 open reading frame 52 | | | | | | Expressed in all |
IVD | Isovaleryl-CoA dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
BAHD1 | Bromo adjacent homology domain containing 1 | | | | | | Expressed in all |
CASC5 | Cancer susceptibility candidate 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
RAD51 | RAD51 recombinase | Cancer-related genes Disease related genes
| | | | | Tissue enhanced |
RMDN3 | Regulator of microtubule dynamics 3 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GCHFR | GTP cyclohydrolase I feedback regulator | | | | | | Expressed in all |
DNAJC17 | DnaJ (Hsp40) homolog, subfamily C, member 17 | | | | | | Expressed in all |
CHP1 | Calcineurin-like EF-hand protein 1 | Plasma proteins
| | | | | Expressed in all |
NDUFAF1 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 1 | Mitochondrial proteins
| | | | | Expressed in all |
RTF1 | Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae) | | | | | | Expressed in all |
ITPKA | Inositol-trisphosphate 3-kinase A | Enzymes
| | | | | Group enriched |
RPAP1 | RNA polymerase II associated protein 1 | Predicted membrane proteins
| | | | | Expressed in all |
PLA2G4E | Phospholipase A2, group IVE | RAS pathway related proteins
| | | | | Tissue enriched |
TMEM87A | Transmembrane protein 87A | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPN3 | Calpain 3, (p94) | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
SNAP23 | Synaptosomal-associated protein, 23kDa | Predicted membrane proteins Transporters
| | | | | Expressed in all |
HAUS2 | HAUS augmin-like complex, subunit 2 | | | | | | Expressed in all |
CDAN1 | Codanin 1 | Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
UBR1 | Ubiquitin protein ligase E3 component n-recognin 1 | Disease related genes Plasma proteins
| | | | | Expressed in all |
CCNDBP1 | Cyclin D-type binding-protein 1 | Predicted secreted proteins
| | | | | Expressed in all |
ZSCAN29 | Zinc finger and SCAN domain containing 29 | Transcription factors
| | | | | Expressed in all |
TP53BP1 | Tumor protein p53 binding protein 1 | Cancer-related genes Disease related genes
| | | | | Expressed in all |
MAP1A | Microtubule-associated protein 1A | FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
PDIA3 | Protein disulfide isomerase family A, member 3 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
ELL3 | Elongation factor RNA polymerase II-like 3 | | | | | | Tissue enhanced |
CASC4 | Cancer susceptibility candidate 4 | | | | | | Expressed in all |
EIF3J | Eukaryotic translation initiation factor 3, subunit J | Plasma proteins
| | | | | Expressed in all |
B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins
| | | | | Group enriched |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | | | | | | Tissue enhanced |
SQRDL | Sulfide quinone reductase-like (yeast) | Mitochondrial proteins
| | | | | Expressed in all |
MYEF2 | Myelin expression factor 2 | | | | | | Mixed |
CTXN2 | Cortexin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC12A1 | Solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
DUT | Deoxyuridine triphosphatase | Enzymes Mitochondrial proteins
| | | | | Expressed in all |